General Announcement for PLC

15/03/2021

OTHERS Local Manufacturing Agreement (Agreement) between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad, and Sinovac Life Sciences Co. Ltd

PHARMANIAGA BERHAD

Type Announcement
Subject OTHERS
Description 
Local Manufacturing Agreement (Agreement) between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad, and Sinovac Life Sciences Co. Ltd

We refer to our announcements dated 12 and 14 January 2021 respectively.

 

The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Lifescience Sdn Bhd (“PLS”), a wholly-owned subsidiary of the Company has on 12 March 2021 entered into an Agreement with Sinovac Life Sciences Co. Ltd., a subsidiary of Sinovac Biotech Ltd. for the purchase of ready-to-fill bulk product of Covid-19 vaccine for manufacturing of Covid-19 vaccine by PLS in Malaysia.

 

Please refer to the attachment for details of the announcement.

 

This announcement is dated 15 March 2021.


Please refer attachment below.


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 15 Mar 2021
Category General Announcement for PLC
Reference Number GA1-11032021-00075


Related Announcements for PHARMA
Date Title
30/03/2022 OTHERS Memorandum of Understanding between Pharmaniaga Manufacturing Berhad and Prime Medical Store L.L.C
25/02/2022 OTHERS Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd and Bio-Innova Co. Ltd
25/02/2022 OTHERS Memorandum of Understanding between Pharmaniaga Lifescience Sdn Bhd & Bionet Asia Co. Ltd.
11/01/2022 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
30/12/2021 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
01/11/2021 MEMORANDUM OF UNDERSTANDING Pharmaniaga Berhad ("Pharmaniaga" or "the Company") Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd, a wholly-owned subsidiary of the Company and National Institutes of Biotechnology Malaysia.
12/08/2021 OTHERS Surat Setuju Terima for the Supply and Distribution of Covid-19 Vaccine Coronavac Suspension for Injection between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad and Government of Malaysia.
07/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
06/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
19/05/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") PROPOSED BONUS ISSUE